17.5 Million Dollars were awarded to Maryland School of Medicine’s Institute for Genome Sciences (IGS) by National Institute of Allergy and Infectious Diseases (NIAID) for the funding of the GCID that is IGS Genome Center for Infectious Diseases for 5 more years.
The Administrative Core Director and the Principal Investigator for the grant, that is titled “A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes,” are Dr. David Rasko and his team investigators that include Dr. Owen R. White and Dr. Claire M. Fraser.
“The GCID team has been in the forefront of applying genomic techniques to advance scientific understanding of infectious disease agents for the past 15 years, and this NIAID grant renewal will allow us to further deploy genomics approaches in the study of host-pathogen-microbiome interactions,” added Doctor Fraser.
The NIAID grant shall be supporting programs of research focusing on 3 major areas. The first involves examining the interactions of several bacteria with one another and with their host or associated microbiome. Dr. Rasko, Dr. Herve S.G. Tettelin, and Dr. Fraser will be leading this research. The 2nd research related to the transcriptomic and genomic analysis of the fungal pathogens that are interacting with their host. Dr. Vincent M. Bruno will be leading this area of research. The last area of research involves an integrated genomics project regarding tropical parasitic diseases. Dr. David Serre, Dr. Julie C. Dunning Hoptopp and an associate professor Dr. Joana C. Silva will lead this research area.
“This grant allows us to integrate the study of multiple pathogens in model systems and with human samples in a way that is more representative of natural infection processes, which will provide greater understanding and more in-depth insights into these interactions,” explained Doctor Rasko.
“Integrating genomics with diagnostic and clinical medicine has advanced our biological understanding of diseases and health,” said the Dean of School of Medicine at the University of Maryland. “This NIAID grant will foster new collaborations across disciplines within the clinical and research centers in the School of Medicine, as well as with international infectious disease communities.”